China SXT Pharmaceuticals (SXTC) News Today $0.39 -0.04 (-10.02%) (As of 11/15/2024 08:55 PM ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsFinancialsSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price DeficiencyOctober 7, 2024 | globenewswire.comChina SXT Pharmaceuticals (NASDAQ:SXTC) Stock, Short Interest ReportOctober 2, 2024 | benzinga.comJAGX, BSGM and SXTC among mid-day moversApril 16, 2024 | msn.comTrading was temporarily halted for "SXTC" at 09:04 AM with a stated reason of "LULD pause."April 16, 2024 | marketbeat.comChina SXT Pharmaceuticals Inc.February 23, 2024 | wsj.comChina SXT Pharmaceuticals Stock (NASDAQ:SXTC) Insider TradesFebruary 23, 2024 | benzinga.comChina SXT Pharmaceuticals, Inc. (SXTC)February 17, 2024 | finance.yahoo.comDow Down 100 Points; US Manufacturing PMI Falls In DecemberJanuary 2, 2024 | markets.businessinsider.comChina SXT Pharma Continues To SpikeDecember 31, 2023 | nasdaq.comChina SXT Pharmaceuticals Inc Ordinary Shares SXTCDecember 20, 2023 | morningstar.comChina SXT Pharmaceuticals, Inc. Regained Compliance with Nasdaq’s Minimum Bid Price RuleOctober 26, 2023 | finance.yahoo.comChina SXT Pharmaceuticals, Inc. Regained Compliance with Nasdaq’s Minimum Bid Price RuleOctober 26, 2023 | finance.yahoo.comTrading was temporarily halted for "SXTC" at 09:10 AM with a stated reason of "LULD pause."October 5, 2023 | marketbeat.comChina SXT Pharmaceuticals, Inc.: China SXT Pharmaceuticals Announces One-for-Twenty-five Reverse Stock SplitOctober 4, 2023 | finanznachrichten.deChina SXT Pharma Ordinary Shares To Begin Trading On Split-Adjusted Basis On Oct. 5October 4, 2023 | markets.businessinsider.comChina SXT Pharmaceuticals Announces One-for-Twenty-five Reverse Stock SplitOctober 4, 2023 | finance.yahoo.comWhy Is China SXT Pharmaceuticals (SXTC) Stock Up 24% Today?September 7, 2023 | investorplace.comSXTC China SXT Pharmaceuticals, Inc.August 25, 2023 | seekingalpha.comWhy Is China SXT Pharmaceuticals (SXTC) Stock Up 110% Today?August 21, 2023 | markets.businessinsider.comChina SXT Pharmaceuticals Full Year 2023 Earnings: US$0.89 loss per share (vs US$5.52 loss in FY 2022)August 2, 2023 | finance.yahoo.comChina SXT Pharmaceuticals, Inc. Receives 180-day Extension from Nasdaq to Meet Minimum Bid Price RuleMay 10, 2023 | finance.yahoo.comInsiders who placed huge bets on China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) earlier this year would be disappointed with the 12% dropMarch 29, 2023 | finance.yahoo.comChina says talks to include Paxlovid in its insurance drug list failJanuary 10, 2023 | reuters.comChina SXT Pharmaceuticals Stock (NASDAQ:SXTC), Quotes and News SummaryJanuary 5, 2023 | benzinga.comChina SXT Pharmaceuticals announces 1-for-20 reverse stock splitMay 18, 2022 | seekingalpha.comWhy Is China SXT Pharmaceuticals (SXTC) Stock Up Today?March 29, 2022 | investorplace.comChina SXT Pharmaceuticals climbs on heavy volumeMarch 29, 2022 | seekingalpha.comChina SXT Pharmaceuticals to raise $2.8M in convertible promissory note offeringMarch 15, 2022 | seekingalpha.comChina SXT Pharmaceuticals, Inc. Enters into Securities Purchase Agreement to Issue a 6% Convertible Promissory Note in the Original Principal Amount of $2.8 MillionMarch 14, 2022 | benzinga.comChina SXT Pharmaceuticals, Inc. Announces Successful Closing of $4.1 Million Follow-on Underwritten Offering of Ordinary Shares and Pre-Funded Warrants With Simultaneous Exercise of the Over-AllotmentJanuary 20, 2022 | finance.yahoo.comAegis Capital Corp. Acted as Sole Bookrunner on a $4.1 Million Underwritten Public Offering of Ordinary Shares, Inclusive of the Over-Allotment, for China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC).January 20, 2022 | finance.yahoo.comChina SXT Pharmaceuticals Shares Plunge On $3.5M Equity Raise Issued At Steep DiscountJanuary 18, 2022 | finance.yahoo.comChina SXT Pharmaceuticals slumps on pricing $3.5M stock, pre-funded warrants offeringJanuary 18, 2022 | seekingalpha.comChina SXT Pharmaceuticals, Inc. Prices $3.5 Million Underwritten Public Offering of Ordinary Shares and Pre-Funded Warrants to Purchase Ordinary SharesJanuary 18, 2022 | finance.yahoo.comChina SXT Pharma announces proposed public offering of shares, prefunded warrantsJanuary 14, 2022 | seekingalpha.comChina SXT Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Ordinary Shares and Pre-Funded Warrants to Purchase Ordinary SharesJanuary 14, 2022 | finance.yahoo.comChina SXT Pharmaceuticals, Inc. Adds Newly Developed Kuihuapan and Zhudanfen Advanced TCMP Products, and Announces the Expected Continuous Growth of Its Production Capacity of LuxuejinJanuary 14, 2022 | finance.yahoo.comChina SXT Pharmaceuticals, Inc. Obtained a New Pharmaceutical Manufacturing Permit and Passed Its GMP Compliance-InspectionOctober 18, 2021 | finance.yahoo.com Get China SXT Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SXTC and its competitors with MarketBeat's FREE daily newsletter. Email Address Bill Gates’ is about to mint millionaires (again) with Stargate. (Ad)This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrough so advanced, it’s going to make ChatGPT look like VHS. But what’s even more unbelievable? I believe it’ll make Nvidia’s meteoric rise look like a backyard bottle rocket. Click here and I’ll tell you everything you need to know. SXTC Media Mentions By Week SXTC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SXTC News Sentiment▼1.430.56▲Average Medical News Sentiment SXTC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SXTC Articles This Week▼20▲SXTC Articles Average Week Get China SXT Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SXTC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Edesa Biotech News TransCode Therapeutics News Pulmatrix News Can-Fite BioPharma News Forte Biosciences News GT Biopharma News Cyclerion Therapeutics News Viracta Therapeutics News Bionomics News Adial Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SXTC) was last updated on 11/18/2024 by MarketBeat.com Staff From Our Partners5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredShocking footage from Bill Gates’ $100,000,000,000 AI BetIf you missed out on Nvidia, watch this video I just made.Brownstone Research | Sponsored🗓️ My First LIVE Event in 5 Years!Give us 60 minutes and we’ll show you how we’ve compressed 15 years of stock market gains into one day.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding China SXT Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share China SXT Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SXTC Stock Alerts